Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Sarepta Therapeutics, Inc.    SRPT

SAREPTA THERAPEUTICS, INC.

(SRPT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about SAREPTA THERAPEUTICS, INC.
03/23Sarepta Therapeutics Announces Fourth Year of Route 79, The Duchenne Scholars..
GL
03/18Sarepta Therapeutics' Investigational Gene Therapy SRP-9003 for the Treatment..
GL
03/15SAREPTA THERAPEUTICS  : P.104 Audhya et al. HRQoL with DMD Study Using HUI
PU
03/15SAREPTA THERAPEUTICS  : P.113 Szabo et al. NSAA & HUI Scores Weakly Correlated A..
PU
03/15SAREPTA THERAPEUTICS  : P.54 Kuntz et al. Casimersen Trmt in Eligible Pts with D..
PU
03/15SAREPTA THERAPEUTICS  : P.90 Cheung et al. Patterns of Clin. Prog. Among Pts wit..
PU
03/15SAREPTA THERAPEUTICS  : P.92 Audhya et al. Prog. to LOA Among Pts with LGMD Syst..
PU
03/15SAREPTA THERAPEUTICS  : P.6 Hadcock et al. Biological Efficacy of PPMO SRP-5051 ..
PU
03/15Sarepta Therapeutics to Present Results from its Gene Therapy and RNA Platfor..
GL
03/14SAREPTA THERAPEUTICS  : 03.18.21_Iff et al._Delay of LOA in DMD Progression with..
PU
03/14SAREPTA THERAPEUTICS  : 03.18.21_Mendell et al._A RCT of rAAVrh74.MHCK7.micro-dy..
PU
03/14SAREPTA THERAPEUTICS  : 03.18.21_Potter et al._Micro-dystrophin Gene Therapy Del..
PU
03/12SAREPTA THERAPEUTICS  : 03.18.21_Rodino-Klapac et al._Safety Exp & Funct Outcome..
PU
03/12SAREPTA THERAPEUTICS  : RBC Capital Adjusts Sarepta Therapeutics PT to $133 From..
MT
03/02SAREPTA THERAPEUTICS  : RBC Capital Adjusts Sarepta Therapeutics' Price Target t..
MT
More most relevant news
All news about SAREPTA THERAPEUTICS, INC.
03/31JOHN MARTIN : John Martin, Who Built Gilead Into HIV, Hepatitis Powerhouse, Dies
DJ
03/23Sarepta Therapeutics Announces Fourth Year of Route 79, The Duchenne Scholars..
GL
03/18Sarepta Therapeutics' Investigational Gene Therapy SRP-9003 for the Treatment..
GL
03/15SAREPTA THERAPEUTICS  : P.104 Audhya et al. HRQoL with DMD Study Using HUI
PU
03/15SAREPTA THERAPEUTICS  : P.113 Szabo et al. NSAA & HUI Scores Weakly Correlated A..
PU
03/15SAREPTA THERAPEUTICS  : P.54 Kuntz et al. Casimersen Trmt in Eligible Pts with D..
PU
03/15SAREPTA THERAPEUTICS  : P.90 Cheung et al. Patterns of Clin. Prog. Among Pts wit..
PU
03/15SAREPTA THERAPEUTICS  : P.92 Audhya et al. Prog. to LOA Among Pts with LGMD Syst..
PU
03/15SAREPTA THERAPEUTICS  : P.6 Hadcock et al. Biological Efficacy of PPMO SRP-5051 ..
PU
03/15Sarepta Therapeutics to Present Results from its Gene Therapy and RNA Platfor..
GL
More news
News in other languages on SAREPTA THERAPEUTICS, INC.
2020ROCHE : Sarepta revendique des progrès contre la myopathie de Duchenne
2020Bourse Zurich: la prudence de retour pour la dernière séance de la semaine
2020ROCHE  : procédure accélérée pour une molécule de Sarepta
2020ROCHE : statut de revue prioritaire pour un médicament contre la DMD
2019EN DIRECT DES MARCHES : Sanofi, Renault, Virbac, Marie Brizard, Recylex, Créd..
2019BIOTECH TIME  : Sensorion, Synthorx, CrossJect, Sarepta, AB Science...
2019Biogen mise sur la thérapie génique avec le rachat de Nightstar
2016Wall Street ouvre sans tendance avant les minutes de la Fed
2016Les valeurs à suivre à Wall Street
2016SAREPTA THERAPEUTICS  : BOURSE-Sarepta s'effondre après un avis négatif de la FD..
More news
Analyst Recommendations on SAREPTA THERAPEUTICS, INC.
03/12SAREPTA THERAPEUTICS  : RBC Capital Adjusts Sarepta Therapeutics PT to $133 From..
MT
03/02SAREPTA THERAPEUTICS  : RBC Capital Adjusts Sarepta Therapeutics' Price Target t..
MT
01/12SAREPTA THERAPEUTICS  : Citigroup Downgrades Sarepta Therapeutics to Neutral fro..
MT
01/11SAREPTA THERAPEUTICS  : UBS Cuts Sarepta Therapeutics to Neutral From Buy, PT to..
MT
01/08SAREPTA THERAPEUTICS  : Baird Adjusts Price Target on Sarepta Therapeutics to $1..
MT
More recommendations
Press releases
03/23Sarepta Therapeutics Announces Fourth Year of Route 79, The Duchenne Scholars..
GL
03/18Sarepta Therapeutics' Investigational Gene Therapy SRP-9003 for the Treatment..
GL
03/15SAREPTA THERAPEUTICS  : P.104 Audhya et al. HRQoL with DMD Study Using HUI
PU
03/15SAREPTA THERAPEUTICS  : P.113 Szabo et al. NSAA & HUI Scores Weakly Correlated A..
PU
03/15SAREPTA THERAPEUTICS  : P.54 Kuntz et al. Casimersen Trmt in Eligible Pts with D..
PU
More press releases
Upcoming event on SAREPTA THERAPEUTICS, INC.